Table 7.
Top ten most consumed parenteral antibiotics in a public hospital in Myanmar (2014 to 2017).
| Hospital | |||||
|---|---|---|---|---|---|
| <200 beds | ≥200 beds | Central | |||
| Antibiotic Substance | Proportion 1 | Antibiotic Substance | Proportion 1 | Antibiotic Substance | Proportion 1 |
| Metronidazole (J01XD01) | 28.0 | Amoxicillin and enzyme inhibitor (J01CR02) | 72.3 | Ceftriaxone (J01DD04) | 27.4 |
| Ceftriaxone (J01DD04) | 24.1 | Procaine benzylpenicillin (J01CE09) | 5.8 | Amoxicillin and enzyme inhibitor (J01CR02) | 15.6 |
| Levofloxacin (J01MA12) | 9.8 | Ceftriaxone (J01DD04) | 5.5 | Metronidazole (J01XD01) | 15.2 |
| Benzylpenicillin (J01CE01) | 6.6 | Levofloxacin (J01MA12) | 3.4 | Levofloxacin (J01MA12) | 9.5 |
| Gentamicin (J01GB03) | 6.1 | Metronidazole (J01XD01) | 1.6 | Benzylpenicillin (J01CE01) | 9.5 |
| Ciprofloxacin (J01MA02) | 5.7 | Ceftazidime (J01DD02) | 1.4 | Ceftazidime (J01DD02) | 4.3 |
| Combinations of penicillins (J01CR50) | 3.6 | Amikacin (J01GB06) | 1.3 | Amikacin (J01GB06) | 4.1 |
| Cefotaxime (J01DD01) | 3.4 | Benzylpenicillin (J01CE01) | 1.3 | Ceftriaxone and enzyme inhibitor (J01DD63) | 3.2 |
| Amoxicillin and enzyme inhibitor (J01CR02) | 2.7 | Ciprofloxacin (J01MA02) | 1.3 | Cefoperazone, combinations (J01DD62) | 2.6 |
| Ofloxacin (J01MA01) | 2.3 | Ceftriaxone and enzyme Inhibitor (J01DD63) | 0.8 | Ciprofloxacin (J01MA02) | 1.4 |
1 This is the proportion on 100% of all antibiotics consumed.